NM_000455.5:c.1225C>T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6BS1BS2

The NM_000455.5(STK11):​c.1225C>T​(p.Arg409Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,588,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R409L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

STK11
NM_000455.5 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:12B:7

Conservation

PhyloP100: 0.172

Publications

15 publications found
Variant links:
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
STK11 Gene-Disease associations (from GenCC):
  • familial pancreatic carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Peutz-Jeghers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.33304822).
BP6
Variant 19-1226570-C-T is Benign according to our data. Variant chr19-1226570-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135917.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0000854 (13/152252) while in subpopulation AFR AF = 0.000193 (8/41464). AF 95% confidence interval is 0.0000956. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 13 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000455.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STK11
NM_000455.5
MANE Select
c.1225C>Tp.Arg409Trp
missense
Exon 9 of 10NP_000446.1A0A0S2Z4D1
STK11
NR_176325.1
n.2492C>T
non_coding_transcript_exon
Exon 10 of 11

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STK11
ENST00000326873.12
TSL:1 MANE Select
c.1225C>Tp.Arg409Trp
missense
Exon 9 of 10ENSP00000324856.6Q15831-1
STK11
ENST00000585748.3
TSL:3
c.853C>Tp.Arg285Trp
missense
Exon 11 of 12ENSP00000477641.2A0A087WT72
STK11
ENST00000593219.6
TSL:3
n.*1050C>T
non_coding_transcript_exon
Exon 10 of 11ENSP00000466610.1K7EMR0

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152252
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000872
AC:
17
AN:
194938
AF XY:
0.0000934
show subpopulations
Gnomad AFR exome
AF:
0.000296
Gnomad AMR exome
AF:
0.0000339
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000108
Gnomad OTH exome
AF:
0.000199
GnomAD4 exome
AF:
0.0000383
AC:
55
AN:
1435836
Hom.:
0
Cov.:
31
AF XY:
0.0000379
AC XY:
27
AN XY:
712116
show subpopulations
African (AFR)
AF:
0.000122
AC:
4
AN:
32854
American (AMR)
AF:
0.0000242
AC:
1
AN:
41258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38114
South Asian (SAS)
AF:
0.0000605
AC:
5
AN:
82652
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49776
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5496
European-Non Finnish (NFE)
AF:
0.0000372
AC:
41
AN:
1100770
Other (OTH)
AF:
0.0000675
AC:
4
AN:
59280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152252
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41464
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.533
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000225
Hom.:
0
Bravo
AF:
0.0000907
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000123
AC:
1
ExAC
AF:
0.0000595
AC:
7

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
6
2
Peutz-Jeghers syndrome (8)
-
1
3
Hereditary cancer-predisposing syndrome (4)
-
3
1
not specified (4)
-
1
1
not provided (2)
-
1
-
Breast carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.56
D
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.66
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.33
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.17
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.24
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.0090
D
Polyphen
0.99
D
Vest4
0.47
MVP
0.24
MPC
0.23
ClinPred
0.12
T
GERP RS
-2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.16
gMVP
0.33
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368466538; hg19: chr19-1226569; COSMIC: COSV53068501; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.